Optimized furosemide taste masked orally disintegrating tablets

被引:23
|
作者
Ibrahim, Mohamed Abbas [1 ,2 ]
Abou El Ela, Amal El Sayeh F. [1 ,3 ]
机构
[1] King Saud Univ, Dept Pharmaceut, Coll Pharm, Riyadh, Saudi Arabia
[2] Al Azhar Univ, Dept Pharmaceut & Ind Pharm, Coll Pharm, Assiut, Egypt
[3] Assiut Univ, Dept Pharmaceut, Coll Pharm, Assiut 71526, Egypt
关键词
Furosemide; Orally disintegrating tablets (ODTs); Eudragit E100; Optimization; Taste masking; Superdisinitgrant; CYCLODEXTRIN INCLUSION COMPLEX; SOLID DISPERSION; BIOAVAILABILITY; FORMULATION; MASKING; DRUGS;
D O I
10.1016/j.jsps.2017.04.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Optimized orally disintegrating tablets (ODTs) containing furosemide (FUR) were prepared by direct compression method. Two factors, three levels (3(2)) full factorial design was used to optimize the effect of taste masking agent (Eudragit E100; X1) and superdisintegarant; croscarmellose sodium (CCS; X2) on tablet properties. A composite was prepared by mixing ethanolic solution of FUR and Eudragit E100 with mannitol prior to mixing with other tablet ingredients. The prepared ODTs were characterized for their FUR content, hardness, friability and wetting time. The optimized ODT formulation (F1) was evaluated in term of palatability parameters and the in vivo disintegration. The manufactured ODTs were complying with the pharmacopeia guidelines regarding hardness, friability, weight variation and content. Eudragit E100 had a very slightly enhancing effect on tablets disintegration. However, the effects of both Eudragit E100 (X1) and CCS (X2) on ODTs disintegration time (Y1) were insignificant (p > 0.05). Moreover, X1 exhibited antagonistic effect on the dissolution after 5 and 30 min (D5 and D30, respectively), but only its effect on D30 is significant (p = 0.0004). Furthermore, the optimized ODTs formula showed good to acceptable taste in term of palatability, and in vivo disintegration time of this formula was about 10 s. (C) 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:1055 / 1062
页数:8
相关论文
共 50 条
  • [31] Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets
    Sotoyama, Mai
    Uchida, Shinya
    Tanaka, Shimako
    Hakamata, Akio
    Odagiri, Keiichi
    Inui, Naoki
    Watanabe, Hiroshi
    Namiki, Noriyuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (04) : 451 - 457
  • [32] Preparation and Evaluation of Orally Rapidly Disintegrating Tablets Containing Taste-Masked Particles Using One-Step Dry-Coated Tablets Technology
    Kondo, Keita
    Niwa, Toshiyuki
    Ozeki, Yuichi
    Ando, Masaki
    Danjo, Kazumi
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2011, 59 (10) : 1214 - 1220
  • [33] The Effects of Screw Configuration and Polymeric Carriers on Hot-Melt Extruded Taste-Masked Formulations Incorporated into Orally Disintegrating Tablets
    Morott, Joseph T.
    Pimparade, Manjeet
    Park, Jun-Bom
    Worley, Chelsea P.
    Majumdar, Soumyajit
    Lian, Zhuoyang
    Pinto, Elanor
    Bi, Yunxia
    Durig, Thomas
    Repka, Michael A.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (01) : 124 - 134
  • [35] Bitterness evaluation of intact and crushed Vesicare orally disintegrating tablets using taste sensors
    Haraguchi, Tamami
    Miyazaki, Airi
    Yoshida, Miyako
    Uchida, Takahiro
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2013, 65 (07) : 980 - 987
  • [36] Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies
    Fu, YR
    Yang, SC
    Jeong, SH
    Kimura, S
    Park, K
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2004, 21 (06): : 433 - 475
  • [37] Taste-masking assessment of orally disintegrating tablets and lyophilisates with cetirizine dihydrochloride microparticles
    Amelian, Aleksandra
    Wasilewska, Katarzyna
    Wesoly, Malgorzata
    Ciosek-Skibinska, Patrycja
    Winnicka, Katarzyna
    SAUDI PHARMACEUTICAL JOURNAL, 2017, 25 (08) : 1144 - 1150
  • [38] Comparison of superdisintegrants in orally disintegrating tablets
    Zhang, Yeli
    Wrzesinski, Amy
    Moses, Marley
    Bertrand, Holly
    Pharmaceutical Technology, 2010, 34 (07) : 54 - 61
  • [39] On the BCS biowaivers of orally disintegrating tablets
    Garcia-Arieta, Alfredo
    Gordon, John
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 66 : 107 - 108
  • [40] PREPARATION OF FAMOTIDINE ORALLY DISINTEGRATING TABLETS
    Olmez, Senem Sevtap
    Vural, Imran
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (01) : 65 - 66